There have been several key news items from the U.S. stent market over the past year. These include the introduction of several new stents, Cordis pulling out of the market, an expanded indication in carotid stenting and development of new stent technology that will likely open a new chapter for percutaneous interventions.


Houston Northwest Medical Center's cardiology department, along with physicians and IT staff, looked at multiple information systems related to cardiology before choosing Horizon Cardiology from McKesson in 2007. The system stood out for several reasons.


Today’s generation of cath lab hemodynamic recording systems do much more than simply measure and monitor a patient’s electrocardiogram, blood pressure and other vital signs. Current systems offer detailed clinical reporting and auto-completion of data fields in the procedure report, help gather registry data, aid in tracking inventory and patient billing, and link images and cine loops to reports.


September 22, 2011 — Stentys S.A., a medical technology company commercializing a self-apposing stent to treat acute myocardial infarction (AMI), announced it has enrolled the 500-patient target of the international APPOSITION III study for its Self-Apposing Stent.

September 22, 2011 — The 15th annual scientific meeting of the Heart Failure Society of America (HFSA) will feature a session titled "Cancer Chemotherapy and Cardiotoxicity" moderated by Daniel J. Lenihan, M.D., professor of medicine at Vanderbilt University. It will focus on the effect of cancer drugs on the presence of heart failure and how oncologists and cardiologists have developed close collaboration in order to benefit patients.

September 22, 2011 — Half the people who have atrial fibrillation deny or don’t know they have a higher risk for stroke, according to a new American Heart Association survey.

Subscribe Now